T1	Treatment 180 202	value-congruence model
T2	Treatment 320 336	made-in-the-U.S.
T3	Treatment 337 345	scenario
T4	Treatment 493 515	made-in-Japan scenario
T5	Treatment 720 747	daily event sampling study)
